During an outpatient well visit with a patient who has sickle cell anemia, you make it PRIORITY to assess the patient's?
Hemoglobin A1C level
Appetite
Reflexes
Vaccination history
The Correct Answer is D
A. Hemoglobin A1C level is not typically assessed in patients with sickle cell anemia as it is primarily used to monitor long-term blood sugar control in individuals with diabetes mellitus.
B. While appetite may be relevant to the overall health of the patient, it is not the priority assessment in a patient with sickle cell anemia.
C. Reflexes may be assessed during the physical examination, but they are not the priority assessment in a patient with sickle cell anemia.
D. Vaccination history is the priority assessment in a patient with sickle cell anemia because individuals with sickle cell disease are at increased risk of infections, particularly from
encapsulated bacteria. Therefore, ensuring that the patient is up-to-date on vaccinations, including pneumococcal and meningococcal vaccines, is crucial for preventing serious infections.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["C","D"]
Explanation
A. The patient experiences a decrease in hemoglobin S. Hydroxyurea does not decrease hemoglobin S levels directly; it works by increasing fetal hemoglobin (Hgb F) levels.
B. The patient experiences dehydration due to diuresis. This is not an indication that Hydroxyurea is working; it is a potential side effect that should be monitored.
C. The patient experiences an increase in fetal hemoglobin (Hbg F). Hydroxyurea works by increasing the levels of fetal hemoglobin, which reduces the sickling of red blood cells.
D. The patient needs fewer blood transfusions. Successful treatment with Hydroxyurea should reduce the frequency of vaso-occlusive crises and the need for blood transfusions.
E. The patient experiences diuresis. This is not an indicator of the medication's effectiveness; it is a potential side effect.
Correct Answer is A
Explanation
A. Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that is used for the prevention and treatment of osteoporosis in postmenopausal women. It helps to prevent bone loss and reduce the risk of fractures by acting similarly to estrogen in some tissues and antagonizing estrogen in others.
B. Levothyroxine is a thyroid hormone replacement medication used to treat hypothyroidism, not osteoporosis.
C. Escitalopram oxalate is an antidepressant medication used to treat depression and anxiety disorders, not osteoporosis.
D. Calcitonin is a hormone involved in calcium regulation, and calcitonin nasal spray is sometimes used in the treatment of osteoporosis, but it is not typically the first-line treatment option.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.